BioLife Solutions Inc (BLFS)
Profitability ratios
Return on sales
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Gross profit margin | 46.06% | 25.21% | -17.59% | 52.63% | 48.59% |
| Operating profit margin | -7.28% | -16.43% | -90.40% | -29.59% | -12.98% |
| Pretax margin | -20.64% | -46.46% | -89.96% | -24.43% | -2.66% |
| Net profit margin | -20.60% | -47.68% | -86.84% | -7.50% | 4.12% |
BioLife Solutions Inc's profitability ratios show fluctuating performance over the years.
- Gross profit margin has generally been strong, improving from 48.59% in 2020 to 52.63% in 2021, but then sharply declining to -17.59% in 2022. However, the margin recovered to 25.21% in 2023 and further improved to 46.06% in 2024.
- Operating profit margin and pretax margin have consistently been negative, indicating that the company has been operating at a loss. The margins show significant improvements from -90.40% in 2022 to -7.28% in 2024 for operating profit margin, and from -89.96% in 2022 to -20.64% in 2024 for pretax margin.
- Net profit margin, which represents the bottom line profitability, was positive at 4.12% in 2020 but turned negative in the following years, reaching a low of -86.84% in 2022. However, there has been some recovery with the margin improving to -20.60% in 2024.
Overall, BioLife Solutions Inc has struggled with profitability, as indicated by the negative margins in operating, pretax, and net profit. The company needs to focus on improving operational efficiency and cost management to enhance profitability in the future.
Return on investment
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | -1.78% | -5.68% | -32.33% | -6.34% | -2.66% |
| Return on assets (ROA) | -5.05% | -16.48% | -31.05% | -1.61% | 0.84% |
| Return on total capital | -2.01% | -19.94% | -37.51% | -7.26% | -3.04% |
| Return on equity (ROE) | -5.78% | -20.14% | -38.39% | -1.86% | 0.97% |
Based on the provided data, BioLife Solutions Inc's profitability ratios show a consistent trend of declining performance over the years analyzed.
1. Operating Return on Assets (Operating ROA):
- The Operating ROA was negative in all years, indicating that the company's core operations were not efficiently generating a return on its assets. The trend worsened significantly from -2.66% in 2020 to -32.33% in 2022, before slightly improving in the subsequent years.
2. Return on Assets (ROA):
- Similarly, the ROA was negative throughout the years, suggesting that the company was not effectively utilizing its assets to generate profits. The ROA declined from 0.84% in 2020 to -31.05% in 2022 before showing some improvement in the later years.
3. Return on Total Capital:
- The Return on Total Capital was also negative across the board, demonstrating that the company's returns were insufficient to cover its total capital employed. The ratio decreased from -3.04% in 2020 to -37.51% in 2022, with some moderation in the following years.
4. Return on Equity (ROE):
- The Return on Equity followed a similar trend of negativity, indicating that the company's profitability in relation to shareholder equity was declining. The ROE plummeted from 0.97% in 2020 to -38.39% in 2022 before slightly recovering in the subsequent years.
Overall, the declining trend in profitability ratios suggests that BioLife Solutions Inc faced challenges in generating profits from its operations and effectively managing its assets and capital over the years analyzed. Further analysis of the company's financial and operational strategies may be warranted to address these profitability issues.